CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	[1]	$ 374,433	$ (87,987)	$ 49,904
Adjustments to net income (loss):
Depreciation and amortization		649,234	633,408	645,292
Deferred income tax expense (benefit)		97,144	21,685	15,881
Impairments and other charges		34,802	26,079	8,318
Amortization of debt discount and deferred financing costs		10,444	8,810	8,735
Bargain purchase gain		(113,653)
Losses (gains) on debt buyback		15,538	14,857	(25,275)
Losses (gains) on sale of long-lived assets, net		(46,873)	27,927	13,920
Share-based compensation		23,383	16,501	15,839
Foreign currency transaction losses (gains), net		5,626	28,150	37,286
Mark-to-market (gain) loss on warrants		(8,359)	(16,894)	(54,684)
Net loss (gain) related to investment in Vast		500	4,575	(7,167)
Gain on disposition of Quail Tools, excluding transaction costs		(432,094)
Other		10,614	5,539	2,427
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	[2]	80,564	(42,440)	(27,129)
Inventory		33,443	16,099	(19,432)
Other current assets		2,531	(4,511)	11,644
Other long-term assets		15,377	(6,478)	(1,283)
Trade accounts payable and accrued liabilities		(51,311)	(25,150)	(32,389)
Income taxes payable		636	(34,590)	24,135
Other long-term liabilities		(8,713)	(4,148)	(28,160)
Net cash provided by (used for) operating activities		693,266	581,432	637,862
Cash flows from investing activities:
Purchases of investments		(4,346)	(7,718)	(38,283)
Cash acquired in stock based business combination, net of cash paid		84,429
Proceeds from disposition of Quail Tools		622,856
Capital expenditures		(715,948)	(567,919)	(540,851)
Proceeds from sales of assets and insurance claims		98,628	15,498	14,133
Other		11,468	4,681	(5,423)
Net cash (used for) provided by investing activities		97,087	(555,458)	(570,424)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		700,000	550,000	900,000
Reduction in debt		(902,676)	(1,197,024)	(298,474)
Debt issuance costs		(11,536)	(11,049)	(18,310)
Proceeds from revolving credit facilities		398,000	315,000	290,000
Reduction in revolving credit facilities		(398,000)	(315,000)	(290,000)
Payment of dividend to former Parker shareholders		(6,052)
Distributions to noncontrolling interest		(875)	(950)	(2,269)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders		(342,371)		(286,366)
Sale of non-controlling interest - special purpose acquisition company				305,000
Other		(3,277)	(3,027)	(6,989)
Net cash (used for) provided by financing activities		(566,787)	(662,050)	592,592
Effect of exchange rate changes on cash and cash equivalents		(3,682)	(15,146)	(22,988)
Net increase (decrease) in cash and cash equivalents and restricted cash		219,884	(651,222)	637,042
Cash and cash equivalents and restricted cash, beginning of period		722,960	1,374,182	737,140
Cash and cash equivalents and restricted cash, end of period		942,844	722,960	1,374,182
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period		389,652	1,057,487	451,025
Restricted cash, beginning of period		333,308	316,695	286,115
Cash and cash equivalents and restricted cash, beginning of period		722,960	1,374,182	737,140
Cash and cash equivalents, end of period		940,707	389,652	1,057,487
Restricted cash, end of period		$ 2,137	$ 333,308	$ 316,695
Restricted cash, Balance Sheet location		Restricted cash held in trust	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period		$ 942,844	$ 722,960	$ 1,374,182

[1] The consolidated income statements include operating activities of consolidated joint ventures. See Note 12—Joint Ventures for additional information.

[2] Includes changes in related party balances of $(1.8) million, $26.3 million and $(3.1) million for the years ended December 31, 2025, 2024 and 2023, respectively.